TickerFacts.

Monopar Therapeutics (MNPR): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-5, first reflected in a filing dated 2024-11-08. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Figures left out. The filed Shares Outstanding for the year ended 2016-12-31 is not shown: zero share count.

6.69M
As of 2025-12-31
6.71M
As of 2026-06-30
12.95M2017-12-31: 9.29M2018-12-31: 9.29M2019-12-31: 10.59M2020-12-31: 11.45M2021-12-31: 12.60M2022-12-31: 12.95M2023-12-31: 2.98M2024-12-31: 6.10M2025-12-31: 6.69M6.69M
2017-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-316.69M+9.7%2026-03-27, Balance as of period end
2024-12-316.10Mn/c2026-03-27, Balance as of period end
2023-12-312.98Mn/c2025-03-31, Balance as of period end
2022-12-3112.95M+2.8%2024-03-28, Balance as of period end
2021-12-3112.60M+10.0%2023-03-23, Balance as of period end
2020-12-3111.45M+8.2%2022-03-24, Balance as of period end
2019-12-3110.59M+14.0%2021-03-25, Balance as of period end
2018-12-319.29M0.0%2020-03-27, Balance as of period end
2017-12-319.29Mn/a2019-02-26, Balance as of period end